We provide you with 20 years of free, institutional-grade data for LIFE stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of LIFE. Explore the full financial landscape of LIFE stock.
| Reported Date | CIK | Ticker | Type |
|---|
aTyr Pharma, Inc(NASDAQ:LIFE) 
aTyr Pharma, Inc., a clinical stage biotherapeutics company, engages in the discovery and development of medicines based on novel immunological pathways in the United States. The company's lead clinical product candidate is ATYR1923, a selective modulator of NRP2 for the treatment of patients with s...
Website: http://www.atyrpharma.com
Founded: 2005
Full Time Employees: 39
Sector: Healthcare
Industry: Biotechnology
The information provided in this report about LIFE stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.